Trial Profile
Effects of Pulsatile Intravenous Insulin Delivery on Hypoglycemic Unawareness.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II/III
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin (Primary) ; Insulin aspart (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Adverse reactions
- 08 Aug 2016 Status changed from discontinued to withdrawn prior to enrolment.
- 12 Mar 2010 New trial record